CN110179121A - 一种改善肠道的五联益生菌组合物、复合固体饮料及其制备方法和应用 - Google Patents
一种改善肠道的五联益生菌组合物、复合固体饮料及其制备方法和应用 Download PDFInfo
- Publication number
- CN110179121A CN110179121A CN201910392441.3A CN201910392441A CN110179121A CN 110179121 A CN110179121 A CN 110179121A CN 201910392441 A CN201910392441 A CN 201910392441A CN 110179121 A CN110179121 A CN 110179121A
- Authority
- CN
- China
- Prior art keywords
- probiotics
- linked
- parts
- intestinal flora
- probiotic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 178
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 178
- 235000013361 beverage Nutrition 0.000 title claims abstract description 55
- 239000007787 solid Substances 0.000 title claims abstract description 55
- 150000001875 compounds Chemical class 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims description 15
- 241000894006 Bacteria Species 0.000 claims abstract description 78
- 230000000968 intestinal effect Effects 0.000 claims abstract description 74
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 39
- 241001465754 Metazoa Species 0.000 claims abstract description 36
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 32
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 32
- 241000692527 Lactobacillus rhamnosus R0011 Species 0.000 claims abstract description 31
- 240000000696 Lactobacillus helveticus R0052 Species 0.000 claims abstract description 29
- 235000005877 Lactobacillus helveticus R0052 Nutrition 0.000 claims abstract description 29
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 29
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 29
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 27
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 27
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 27
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 27
- 241000917009 Lactobacillus rhamnosus GG Species 0.000 claims abstract description 25
- 229940059406 lactobacillus rhamnosus gg Drugs 0.000 claims abstract description 24
- 208000004926 Bacterial Vaginosis Diseases 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims description 19
- 239000002994 raw material Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 15
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 235000013406 prebiotics Nutrition 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 abstract description 23
- 230000001580 bacterial effect Effects 0.000 abstract description 10
- 206010000059 abdominal discomfort Diseases 0.000 abstract description 8
- 230000001976 improved effect Effects 0.000 abstract description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 7
- 206010012735 Diarrhoea Diseases 0.000 abstract description 5
- 230000028993 immune response Effects 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 27
- 230000000694 effects Effects 0.000 description 20
- 230000006872 improvement Effects 0.000 description 16
- 238000010790 dilution Methods 0.000 description 13
- 239000012895 dilution Substances 0.000 description 13
- 239000006071 cream Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 238000012856 packing Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 8
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 8
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 206010028813 Nausea Diseases 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 210000000987 immune system Anatomy 0.000 description 5
- 230000008693 nausea Effects 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 208000012895 Gastric disease Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 240000002605 Lactobacillus helveticus Species 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010012438 Dermatitis atopic Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000590002 Helicobacter pylori Species 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 201000008937 atopic dermatitis Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000004443 dendritic cell Anatomy 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 208000024798 heartburn Diseases 0.000 description 3
- 229940037467 helicobacter pylori Drugs 0.000 description 3
- 229940054346 lactobacillus helveticus Drugs 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 229940092253 ovalbumin Drugs 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 230000005186 women's health Effects 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 206010000050 Abdominal adhesions Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 101000984728 Chiropsoides quadrigatus Angiotensin-converting enzyme inhibitory peptide Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102100033238 Elongation factor Tu, mitochondrial Human genes 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 101710103182 Feruloyl esterase B Proteins 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010049977 Peptide Elongation Factor Tu Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 108010079723 Shiga Toxin Proteins 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 210000000447 Th1 cell Anatomy 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 208000037009 Vaginitis bacterial Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000000139 costimulatory effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021001 fermented dairy product Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000007474 system interaction Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000020192 tolerance induction in gut-associated lymphoid tissue Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 230000002034 xenobiotic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910392441.3A CN110179121A (zh) | 2019-05-13 | 2019-05-13 | 一种改善肠道的五联益生菌组合物、复合固体饮料及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910392441.3A CN110179121A (zh) | 2019-05-13 | 2019-05-13 | 一种改善肠道的五联益生菌组合物、复合固体饮料及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110179121A true CN110179121A (zh) | 2019-08-30 |
Family
ID=67714474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910392441.3A Pending CN110179121A (zh) | 2019-05-13 | 2019-05-13 | 一种改善肠道的五联益生菌组合物、复合固体饮料及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110179121A (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110916188A (zh) * | 2019-12-23 | 2020-03-27 | 安徽新熙盟生物科技有限公司 | 一种含有益生菌和魔芋提取物的组合物及制备方法和应用 |
CN111034891A (zh) * | 2019-12-30 | 2020-04-21 | 杭州海王生物工程有限公司 | 一种含益生菌组合物的固体饮料及其制备方法 |
CN111346115A (zh) * | 2020-04-03 | 2020-06-30 | 尚赫(天津)科技开发有限公司 | 益生菌组合物及其产品和制备方法 |
CN111529703A (zh) * | 2020-06-17 | 2020-08-14 | 湖南唯乐可健康产业有限公司 | 一种组合物及其制备方法与在制备免疫佐剂中的应用 |
CN111671079A (zh) * | 2020-05-13 | 2020-09-18 | 优益生活(北京)健康科技有限公司 | 一种复合益生菌粉组合物及其制备方法 |
CN111685255A (zh) * | 2020-06-08 | 2020-09-22 | 杭州娃哈哈科技有限公司 | 一种增强免疫功能的益生菌固体饮料及其制备方法 |
CN112056481A (zh) * | 2020-09-30 | 2020-12-11 | 上海恒腾生物科技有限公司 | 一种活性益生菌固体饮料配方及其制备方法 |
CN112167639A (zh) * | 2020-09-29 | 2021-01-05 | 龚代银 | 一种双向调节晨起肠道液体平衡的组合物、制备方法及其用途 |
US20210060099A1 (en) * | 2019-09-04 | 2021-03-04 | Amare Global | Nutritional supplements and methods of nutritional supplementation affecting microbiome metabolism |
CN112877233A (zh) * | 2021-01-23 | 2021-06-01 | 江苏斯卡露生物科技有限公司 | 一种瑞士乳杆菌菌株及其应用 |
CN113115950A (zh) * | 2021-05-21 | 2021-07-16 | 湖南康琪壹佰生物科技有限公司 | 一种调节肠道菌群的食品及其制备方法 |
CN113826692A (zh) * | 2021-08-27 | 2021-12-24 | 山西振东五和健康科技股份有限公司 | 一种益生菌固体饮料及其制备方法 |
CN114886068A (zh) * | 2022-05-20 | 2022-08-12 | 深圳市泛乐电子商务有限公司 | 一种复合益生菌固体饮料 |
CN115404187A (zh) * | 2022-09-15 | 2022-11-29 | 广州能靓生物技术有限公司 | 一种体重管理及减压的益生菌组合物 |
CN115518121A (zh) * | 2022-09-28 | 2022-12-27 | 广州能靓生物技术有限公司 | 一种含益生菌的组合物及其应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120207712A1 (en) * | 2009-01-12 | 2012-08-16 | Pfizer Italia S.R.L. | Compositions Comprising Probiotic and Prebiotic Components and Mineral Salts, with Lactoferrin |
CN103764154A (zh) * | 2011-06-10 | 2014-04-30 | 普洛特拉有限公司 | 包含片球菌属的药物组合物和减轻胃肠综合征的症状的方法 |
CN105454966A (zh) * | 2015-12-11 | 2016-04-06 | 苏州泽达兴邦医药科技有限公司 | 改善胃肠道且提高免疫力的益生菌固体饮料及其制备方法 |
CN106581081A (zh) * | 2017-02-12 | 2017-04-26 | 无比滴(广东)药业有限公司 | 一种含有多种益生菌株的益生菌 |
CN108771072A (zh) * | 2018-04-25 | 2018-11-09 | 深圳市多微生保健食品有限公司 | 一种益生菌组合物及婴幼儿益生菌固体饮料 |
CN108902981A (zh) * | 2018-04-25 | 2018-11-30 | 深圳市多微生保健食品有限公司 | 一种益生菌组合物及益生菌固体饮料 |
-
2019
- 2019-05-13 CN CN201910392441.3A patent/CN110179121A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120207712A1 (en) * | 2009-01-12 | 2012-08-16 | Pfizer Italia S.R.L. | Compositions Comprising Probiotic and Prebiotic Components and Mineral Salts, with Lactoferrin |
CN103764154A (zh) * | 2011-06-10 | 2014-04-30 | 普洛特拉有限公司 | 包含片球菌属的药物组合物和减轻胃肠综合征的症状的方法 |
CN105454966A (zh) * | 2015-12-11 | 2016-04-06 | 苏州泽达兴邦医药科技有限公司 | 改善胃肠道且提高免疫力的益生菌固体饮料及其制备方法 |
CN106581081A (zh) * | 2017-02-12 | 2017-04-26 | 无比滴(广东)药业有限公司 | 一种含有多种益生菌株的益生菌 |
CN108771072A (zh) * | 2018-04-25 | 2018-11-09 | 深圳市多微生保健食品有限公司 | 一种益生菌组合物及婴幼儿益生菌固体饮料 |
CN108902981A (zh) * | 2018-04-25 | 2018-11-30 | 深圳市多微生保健食品有限公司 | 一种益生菌组合物及益生菌固体饮料 |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210060099A1 (en) * | 2019-09-04 | 2021-03-04 | Amare Global | Nutritional supplements and methods of nutritional supplementation affecting microbiome metabolism |
CN110916188A (zh) * | 2019-12-23 | 2020-03-27 | 安徽新熙盟生物科技有限公司 | 一种含有益生菌和魔芋提取物的组合物及制备方法和应用 |
CN111034891A (zh) * | 2019-12-30 | 2020-04-21 | 杭州海王生物工程有限公司 | 一种含益生菌组合物的固体饮料及其制备方法 |
CN111346115A (zh) * | 2020-04-03 | 2020-06-30 | 尚赫(天津)科技开发有限公司 | 益生菌组合物及其产品和制备方法 |
CN111671079A (zh) * | 2020-05-13 | 2020-09-18 | 优益生活(北京)健康科技有限公司 | 一种复合益生菌粉组合物及其制备方法 |
CN111685255A (zh) * | 2020-06-08 | 2020-09-22 | 杭州娃哈哈科技有限公司 | 一种增强免疫功能的益生菌固体饮料及其制备方法 |
CN111529703A (zh) * | 2020-06-17 | 2020-08-14 | 湖南唯乐可健康产业有限公司 | 一种组合物及其制备方法与在制备免疫佐剂中的应用 |
CN111529703B (zh) * | 2020-06-17 | 2023-09-15 | 湖南循天然营养有限公司 | 一种组合物及其制备方法与在制备免疫佐剂中的应用 |
CN112167639A (zh) * | 2020-09-29 | 2021-01-05 | 龚代银 | 一种双向调节晨起肠道液体平衡的组合物、制备方法及其用途 |
CN112056481A (zh) * | 2020-09-30 | 2020-12-11 | 上海恒腾生物科技有限公司 | 一种活性益生菌固体饮料配方及其制备方法 |
CN112877233B (zh) * | 2021-01-23 | 2021-12-10 | 江苏斯卡露生物科技有限公司 | 一种瑞士乳杆菌菌株及其应用 |
CN112877233A (zh) * | 2021-01-23 | 2021-06-01 | 江苏斯卡露生物科技有限公司 | 一种瑞士乳杆菌菌株及其应用 |
CN113115950A (zh) * | 2021-05-21 | 2021-07-16 | 湖南康琪壹佰生物科技有限公司 | 一种调节肠道菌群的食品及其制备方法 |
CN113826692A (zh) * | 2021-08-27 | 2021-12-24 | 山西振东五和健康科技股份有限公司 | 一种益生菌固体饮料及其制备方法 |
CN114886068A (zh) * | 2022-05-20 | 2022-08-12 | 深圳市泛乐电子商务有限公司 | 一种复合益生菌固体饮料 |
CN115404187A (zh) * | 2022-09-15 | 2022-11-29 | 广州能靓生物技术有限公司 | 一种体重管理及减压的益生菌组合物 |
CN115518121A (zh) * | 2022-09-28 | 2022-12-27 | 广州能靓生物技术有限公司 | 一种含益生菌的组合物及其应用 |
CN115518121B (zh) * | 2022-09-28 | 2023-10-20 | 广州能靓生物技术有限公司 | 一种含益生菌的组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110179121A (zh) | 一种改善肠道的五联益生菌组合物、复合固体饮料及其制备方法和应用 | |
Sen | Role of probiotics in health and disease–A review | |
US11419885B2 (en) | Compositions for use in the prevention or treatment of URT infections in infants or young children at risk | |
CN102123715B (zh) | 刺激免疫系统的营养物 | |
RU2448720C2 (ru) | Синбиотическая смесь | |
EP2552464B1 (en) | Use of bifidobacteria for preventing allergy in breastfed infants | |
CN112175864B (zh) | 动物双歧杆菌及其选育方法和应用 | |
JP2014516589A (ja) | プロバイオティック組成物及び方法(probioticcompositionandmethods) | |
TWI744311B (zh) | 以新生兒為對象的腦功能改善用組成物 | |
CN108882740A (zh) | 含有不可消化寡糖的发酵配方物 | |
CN112273657A (zh) | 用于预防或改善过敏性疾病的益生菌组合物、制法和应用 | |
US10369177B2 (en) | Agent for improving or maintaining QOL | |
CN108938789A (zh) | 一种含有低聚木糖的调节肠道微生态多菌联合制剂 | |
CN1305383C (zh) | 一种含有双歧杆菌冻干粉的奶粉制品及其制备方法 | |
CN111972497A (zh) | 提高免疫力改善便秘的儿童配方奶粉及其制备方法 | |
US20230227771A1 (en) | Pre-conditioning of l.reuteri | |
JP2024517546A (ja) | 最終製剤中のgosプレコンディショニングl.ロイテリ(l.reuteri)及びgos | |
TW202202160A (zh) | 促進排便的組成物及其應用 | |
TWI705817B (zh) | 胚芽乳酸桿菌twk10用於製備抗運動後發炎醫藥組合物之用途 | |
CN112640958A (zh) | 适合腹泻儿童食用的营养羊奶粉及其制备方法和应用 | |
CN117940026A (zh) | 用于制备发酵乳产品的方法 | |
Hiregoudar et al. | Probiotic Fermented Foods: Healthy Way to Healthy Life | |
TW202027621A (zh) | 胚芽乳酸桿菌twk10用於製備降體脂醫藥組合物之用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Building A41, Liandong Jinyu Industrial Center, No. 308, Section 2, Maqiao River, Wangcheng Economic and Technological Development Zone, Changsha City, Hunan Province 410000 Applicant after: Hunan Sunshine Pharmaceutical Technology Co., Ltd. Address before: Building A41, Liandong Jinyu Industrial Center, No. 308, Section 2, Maqiao River, Wangcheng Economic and Technological Development Zone, Changsha City, Hunan Province 410000 Applicant before: Hunan Weile Ke Health Industry Co.,Ltd. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220803 Address after: Building A41, Liandong U Valley, No. 308, Maqiaohe Road, Wangcheng Economic and Technological Development Zone, Changsha City, Hunan Province 410000 Applicant after: Hunan Xun Natural Nutrition Co., Ltd. Address before: Building A41, Liandong Jinyu Industrial Center, No. 308, Section 2, Maqiao River, Wangcheng Economic and Technological Development Zone, Changsha City, Hunan Province 410000 Applicant before: Hunan Sunshine Pharmaceutical Technology Co., Ltd. |
|
TA01 | Transfer of patent application right |